ATE123032T1 - Makrocyclische stickstoffliganden verfahren zu ihrer herstellung, ihre metallkomplexe, sie enthaltende diagnostische und therapeutische mittel. - Google Patents

Makrocyclische stickstoffliganden verfahren zu ihrer herstellung, ihre metallkomplexe, sie enthaltende diagnostische und therapeutische mittel.

Info

Publication number
ATE123032T1
ATE123032T1 AT90400815T AT90400815T ATE123032T1 AT E123032 T1 ATE123032 T1 AT E123032T1 AT 90400815 T AT90400815 T AT 90400815T AT 90400815 T AT90400815 T AT 90400815T AT E123032 T1 ATE123032 T1 AT E123032T1
Authority
AT
Austria
Prior art keywords
diagnostic
therapeutic agents
production
ligands
complexes
Prior art date
Application number
AT90400815T
Other languages
English (en)
Inventor
Suzan C Jackels
Dominique Meyer
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Application granted granted Critical
Publication of ATE123032T1 publication Critical patent/ATE123032T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
AT90400815T 1989-03-24 1990-03-23 Makrocyclische stickstoffliganden verfahren zu ihrer herstellung, ihre metallkomplexe, sie enthaltende diagnostische und therapeutische mittel. ATE123032T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903938A FR2644785B1 (fr) 1989-03-24 1989-03-24 Nouveaux ligands macrocycliques azotes, procede de preparation, complexes metalliques formes par ces ligands et composition de diagnostic les contenant

Publications (1)

Publication Number Publication Date
ATE123032T1 true ATE123032T1 (de) 1995-06-15

Family

ID=9380062

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400815T ATE123032T1 (de) 1989-03-24 1990-03-23 Makrocyclische stickstoffliganden verfahren zu ihrer herstellung, ihre metallkomplexe, sie enthaltende diagnostische und therapeutische mittel.

Country Status (6)

Country Link
EP (1) EP0391766B1 (de)
JP (1) JPH04506955A (de)
AT (1) ATE123032T1 (de)
DE (1) DE69019584T2 (de)
FR (1) FR2644785B1 (de)
WO (1) WO1990011282A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001655A1 (de) * 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5334371A (en) * 1988-07-20 1994-08-02 Schering Aktiengesellschaft Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI
CA2072080A1 (en) * 1990-01-19 1991-07-20 Jo Klaveness Chelating compounds
GB9001245D0 (en) * 1990-01-19 1990-03-21 Salutar Inc Compounds
US5367080A (en) * 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
CA2072934C (en) * 1991-07-19 2007-08-28 Karl William Aston Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
US5480990A (en) * 1991-12-10 1996-01-02 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes for use as contrast agents
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
IL104062A0 (en) * 1991-12-10 1993-05-13 Dow Chemical Co Bicyclopolyazamacrocyclophosphonic acid complexes,their conjugates,processes for their preparation,and use as radiopharmaceuticals
JPH07502043A (ja) * 1991-12-10 1995-03-02 ザ　ダウ　ケミカル　カンパニー ビシクロポリアザ大環状ホスホン酸、結合体、造影剤及び製造
WO1994026754A1 (en) * 1993-05-06 1994-11-24 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
AU3415493A (en) * 1991-12-10 1993-07-19 Dow Chemical Company, The Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents
WO1994026313A1 (en) * 1993-05-06 1994-11-24 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
US6204259B1 (en) 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
AU4239893A (en) * 1993-05-06 1994-12-12 Dow Chemical Company, The Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals
WO1994026315A1 (en) * 1993-05-06 1994-11-24 The Dow Chemical Company Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as radiopharmaceuticals
US6207826B1 (en) 1995-03-27 2001-03-27 Isis Pharmaceuticals, Inc. Macrocyclic compounds having nitrogen-containing linkages
EP0817787A4 (de) * 1995-03-27 2000-09-13 Isis Pharmaceuticals Inc Makrozyklische stickstoffverbindungen
US6525041B1 (en) 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
BR9610241A (pt) 1995-08-17 1999-06-29 Monsanto Co Processos para análise de imagem de diagnóstico utilizando bioconjgados de complexos de metal de ligandos macrocíclicos contendo nitrogênio
IL126659A (en) * 1996-04-19 2003-05-29 Dow Global Technologies Inc Fluorescent chelates as visual tissue specific imaging agents
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
WO2012124310A1 (en) * 2011-03-11 2012-09-20 B.R.A.H.M.S Gmbh Rare earth metal complex having phenanthroline compound as ligand
WO2017089848A1 (en) 2015-11-26 2017-06-01 Debreceni Egyetem New 2, 1 l -diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based mri contrast agents and 52mn based pet contrast agents
WO2017089847A1 (en) 2015-11-26 2017-06-01 Debreceni Egyetem New 3,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca- 1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
US10494379B2 (en) 2015-11-26 2019-12-03 Debreceni Egyetem 6-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents
FR3046172B1 (fr) * 2015-12-24 2019-05-31 Guerbet Ligands macrocycliques avec groupement(s) picolinate(s), leurs complexes ainsi que leurs utilisations medicales
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8502573D0 (sv) * 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
DE4001655A1 (de) * 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
GB9001245D0 (en) * 1990-01-19 1990-03-21 Salutar Inc Compounds
CA2072080A1 (en) * 1990-01-19 1991-07-20 Jo Klaveness Chelating compounds
US5114688A (en) * 1990-01-23 1992-05-19 L'air Liquide, Societe Anonyme Pour L'etude Et Exploitation Des Procedes Georges Claude Binuclear metal macrocyclic and macrobicyclic complexes for oxygen separation and transport

Also Published As

Publication number Publication date
EP0391766A1 (de) 1990-10-10
EP0391766B1 (de) 1995-05-24
WO1990011282A1 (fr) 1990-10-04
DE69019584D1 (de) 1995-06-29
JPH04506955A (ja) 1992-12-03
FR2644785A1 (fr) 1990-09-28
FR2644785B1 (fr) 1991-07-05
DE69019584T2 (de) 1995-11-09

Similar Documents

Publication Publication Date Title
ATE123032T1 (de) Makrocyclische stickstoffliganden verfahren zu ihrer herstellung, ihre metallkomplexe, sie enthaltende diagnostische und therapeutische mittel.
ZA882552B (en) Nitrogen-containing cyclic ligands,metallic complexes formed by these ligands,diagnostic compositions containing these complexes and process for the preparation of the ligands
FR2672051B1 (fr) Nouveaux ligands macrocycliques azotes, procede de preparation, complexes polymetalliques, composition de diagnostic et therapeutique.
ATE108771T1 (de) Chelatbildner zur komplexierung von radioaktiven isotopen, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie.
GB1489330A (en) Stable diagnostic reagents
IL143730A0 (en) Blood pool agents for nuclear magnetic resonance diagnostics
DE59408142D1 (de) Chelatbildner vom typ xn 1?s 1?o 1? für radioaktive isotope, deren metallkomplexe und ihre verwendung in diagnostik und therapie
ATE106751T1 (de) Mittel für magnetische resonanzbilderzeugung.
ATE151406T1 (de) Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung als nmr- und röntgenkontrastmittel und verfahren zu deren herstellung
DE68922686T2 (de) Zyklische, Stickstoff enthaltende Liganden, ihre Metallkomplexe, diese enthaltende Diagnostik-Mittel und Verfahren zur Herstellung der Liganden.
DE19641197A1 (de) Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel
WO1995022527A1 (de) 4,4-disubstituierte piperidinderivate als vierzahnige liganden zur komplexierung von nukliden in der nuklearmedizin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties